Another “breakthrough” in prostate cancer research? Hmmm?

In a hype-laden media release from the 16th World Congress on Advances in Oncology and 14th International Symposium on Molecular Medicine ongoing in Rhodes, Greece, comes another of those “breakthrough” claims with no actual data.

The media and the two major prostate cancer screening trials

An unexpected publication in the urology literature is an article analyzing the ways in which selected major media reported on the results of the Prostate Lung Colorectal Ovarian Cancer (PLCO) and the European Randomized Study of Screening for Prostate Cancer (ERSPC) trials after their publication in the New England Journal of Medicine in early 2009.

A study in media management for prostate cancer support group leaders

There has been a prostate cancer furore in Las Vegas, where a locally respected urologist has had his medical license suspended after being accused of re-using single-use needle guides in the conduct of prostate biopsies (see this article from the Las Vegas Review-Journal).

Media highly focused on expected Provenge approval

There has been a flurry of media stories as the “drop dead date” for a decision about approval of sipuleucel-T (Provenge) gets closer and closer.

The monoclonal antibody F77 and media “over-hype”

“Found, the super molecule to kill prostate cancer cells,” trumpeted the MailOnline. And worse still, “A miracle molecule has been discovered that offers the hope of saving men with currently incurable prostate cancer,” screamed the Press Association.

Media misrepresentation, diet, and prostate cancer

There’s a new diet and prostate cancer story “doing the rounds” in the media. It started out stating that dietary changes can induce “substantial” effects on PSA doubling times among men who have received first-line treatment for prostate cancer. The problem with the story is that is based on a small pilot study published last [...]

Follow

Get every new post delivered to your Inbox.

Join 268 other followers